Pancreatic pathology: A practical review

Laboratory Medicine

Volumn 40, Issue 7, 2009, Pages 417-426

  Bellizzi, Andrew M ^a   Frankel, Wendy L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CHROMOGRANIN; SYNAPTOPHYSIN; TRYPSIN;

CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOCARCINOMA; CYSTADENOMA; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PANCREAS DUCT; PANCREAS ISLET CELL TUMOR; PANCREAS PSEUDOCYST; REVIEW;

EID: 77952171960     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/LM5MY3OCDWWKS6NM     Document Type: Review

References (68)

1. Hruban RH, Pitman, MB, Klimstra, DS. Ductal adenocarcinoma afip atlas of tumor pathology: Tumors of the pancreas. Am J Clin Pathol. 2007;6:111-164.
2. Kloppel G, Hruban RH, Longnecker, DS, et al. Ductal adenocarcinoma of the pancreas. Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000; 221-230.
3. Tamm E, Charnsangavej C. Pancreatic cancer: Current concepts in imaging for diagnosis and staging. Cancer J. 2001;7:298-311.
4. Rafique A, Freeman S, Carroll N. A clinical algorithm for the assessment of pancreatic lesions: Utilization of 16- and 64-section multidetector CT and endoscopic ultrasound. Clin Radiol. 2007;62:1142-1153.
5. Katz MH, Wang H, Fleming JB, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009.
6. Nieto J, Grossbard ML, Kozuch P. Metastatic pancreatic cancer 2008: Is the glass less empty? Oncologist. 2008;13:562-576.
7. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: Are they all 'chronic pancreatitis'? Am J Surg Pathol. 2003;27:110-120.
8. Proca DM, Ellison EC, Hibbert D, et al. Major pancreatic resections for chronic pancreatitis. Arch Pathol Lab Med. 2001;125:1051-1054.
9. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: A systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537-1545.
10. Kojima M, Sipos B, Klapper W, et al. Autoimmune pancreatitis: Frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol. 2007;31:521-528.
11. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28(8):977-987.
12. Albores-Saavedra J, Wu J, Crook T, et al. Intestinal and oncocytic variants of pancreatic intraepithelial neoplasia. A morphological and immunohistochemical study. Ann Diagn Pathol. 2005;9:69-76.
13. Albores-Saavedra J, Weimersheimer-Sandoval M, Chable-Montero F, et al. The foamy variant of pancreatic intraepithelial neoplasia. Ann Diagn Pathol. 2008;12(4):252-259.
14. Rosty C, Geradts J, Sato N, et al. p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis. Am J Surg Pathol. 2003;27:1495-1501.
15. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 1997;57:2140-2143.
16. Brat DJ, Lillemoe KD, Yeo CJ, et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol. 1998;22:163-169.
17. Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that Dpc4 inactivation occurs late in neoplastic progression. Cancer Res. 2000;60:2002-2006.
18. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg. 1997;226:248-257; discussion 257-260.
19. Campanale RP, 2nd, Frey CF, Farias LR, et al. Reliability and sensitivity of frozen-section pancreatic biopsy. Arch Surg. 1985;120:283-288.
20. Cioc AM, Ellison EC, Proca DM, et al. Frozen section diagnosis of pancreatic lesions. Arch Pathol Lab Med. 2002;126:1169-1173.
21. Holaday WJ, Assor D. Ten thousand consecutive frozen sections. A retrospective study focusing on accuracy and quality control. Am J Clin Pathol. 1974;61(6):769-777.
22. Hyland C, Kheir SM, Kashlan MB. Frozen section diagnosis of pancreatic carcinoma: A prospective study of 64 biopsies. Am J Surg Pathol. 1981;5:179-191.
23. Bartow SA, Mukai K, Rosai J. Pseudoneoplastic proliferation of endocrine cells in pancreatic fibrosis. Cancer. 1981;47:2627-2633.
24. Adsay V, Logani S, Sarkar F, et al. Foamy gland pattern of pancreatic ductal adenocarcinoma: A deceptively benign-appearing variant. Am J Surg Pathol. 2000;24:493-504.
25. Allaire GS, Rabin L, Ishak KG, et al. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol. 1988;12:708-715.
26. Bloomston M, Muscarella P, Shah MH, et al. Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas. J Gastrointest Surg. 2006;10:1361-1370.
27. Bellizzi AM, Stelow, EB. Pancreatic cytopathology: A practical approach and review. Arch Pathol Lab Med. 2009 (In Press).
28. Zamboni G, Kloppel, G, Hruban, RH, et al. Mucinous cystic neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 234-236.
29. Longnecker DS, Adler, G, Hruban, RH, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen, LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 237-240.
30. Hruban RH, Pitman, MB, Klimstra, DS. Mucinous Cystic Neoplasms AFIP Atlas of Tumor Pathology: Tumors of the Pancreas. Vol.6. Washington, DC: American Registry of Pathology; 2007: 51-74.
31. Hruban RH, Pitman, MB, Klimstra, DS. Intraductal Neoplasms AFIP Atlas of Tumor Pathology: Tumors of the Pancreas. Vol.6. Washington, DC: American Registry of Pathology; 2007: 75-110.
32. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
33. Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: Differences in clinical characteristics and surgical management. Arch Surg. 1999;134:1131-1136.
34. Bardales RH, Stelow EB, Mallery S, et al. Review of endoscopic ultrasound-guided fine-needle aspiration cytology. Diagn Cytopathol. 2006;34:140-175.
35. Stelow EB, Stanley MW, Bardales RH, et al. Intraductal papillary-mucinous neoplasm of the pancreas. The findings and limitations of cytologic samples obtained by endoscopic ultrasound-guided fine-needle aspiration. Am J Clin Pathol. 2003;120:398-404.
36. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: A pooled analysis. Gastrointest Endosc. 2005;62:383-389.
37. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-1095.
38. Adsay NV, Longnecker DS, Klimstra DS. Pancreatic tumors with cystic dilatation of the ducts: Intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol. 2000;17:16-30.
39. D'Angelica M, Brennan MF, Suriawinata AA, et al. Intraductal papillary mucinous neoplasms of the pancreas: An analysis of clinicopathologic features and outcome. Ann Surg. 2004;239:400-408.
40. Yamao K, Nakamura T, Suzuki T, et al. Endoscopic diagnosis and staging of mucinous cystic neoplasms and intraductal papillary-mucinous tumors. J Hepatobiliary Pancreat Surg. 2003;10:142-146.
41. Thompson LD, Becker RC, Przygodzki RM, et al. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: A clinicopathologic study of 130 cases. Am J Surg Pathol. 1999;23:1-16.
42. Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: Clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23:410-422.
43. Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: Demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol. 2004;2:1026.
44. Alpert LC, Truong LD, Bossart MI, et al. Microcystic adenoma (serous cystadenoma) of the pancreas. A study of 14 cases with immunohistochemical and electron-microscopic correlation. Am J Surg Pathol. 1988;12:251.
45. Capella C, Solcia, E, Kloppel, G, et al. Serous cystic neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 231
46. Hruban RH, Pitman, MB, Klimstra, DS. Serous Cystic Neoplasms AFIP Atlas of Tumor Pathology: Tumors of the Pancreas. Vol.6. Washington, DC: American Registry of Pathology; 2007: 33-50.
47. Stern JR, Frankel WL, Ellison EC, et al. Solid serous microcystic adenoma of the pancreas. World J Surg Oncol. 2007;5:26.
48. Kosmahl M, Wagner J, Peters K, et al. Serous cystic neoplasms of the pancreas: An immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol. 2004;28:339-346.
49. Marsh WL, Colonna, J, Yearsley, M, et al. Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors. Appl Immunohistochem Mol Morphol. 2008 (in press).
50. Eriguchi N, Aoyagi S, Nakayama T, et al. Serous cystadenocarcinoma of the pancreas with liver metastases. J Hepatobiliary Pancreat Surg. 1998;5:467-470.
51. Adsay NV, Klimstra DS. Cystic forms of typically solid pancreatic tumors. Semin Diagn Pathol. 2000;17:81-88.
52. Heitz PU, Komminoth P, Perren A, et al. Pancreatic endocrine tumours. In: DeLellis RA LR, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press, 2004: 175-208.
53. Hruban RH, Pitman, MB, Klimstra, DS. Endocrine Neoplasms AFIP Atlas of Tumor Pathology: Tumors of the Pancreas. Vol.6. Washington, DC: American Registry of Pathology; 2007: 251-304.
54. Frankel WL. Update on pancreatic endocrine tumors. Arch Pathol Lab Med. 2006;130:963-966.
55. Capella C, Heitz PU, Hofler H, et al. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995;425:547-560.
56. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: An analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol. 2002;20:2633-2642.
57. La Rosa S, Sessa F, Capella C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 1996;429:323-333.
58. Deshpande V, Fernandez-del Castillo C, Muzikansky A, et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol. 2004;28:1145-1153.
59. Deschamps L, Handra-Luca A, O'Toole D, et al. CD10 expression in pancreatic endocrine tumors: Correlation with prognostic factors and survival. Hum Pathol. 2006;37:802-808.
60. Kloppel G, Luttges J, Klimstra D, et al. Solid-pseudopapillary neoplasm. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 246-248.
61. Tanaka Y, Notohara K, Kato K, et al. Usefulness of beta-catenin immunostaining for the differential diagnosis of solid-pseudopapillary neoplasm of the pancreas. Am J Surg Pathol. 2002;26:818-820.
62. Serra S, Salahshor S, Fagih M, et al. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas. JOP. 2007;8:296-303.
63. Klimstra DS, Wenig BM, Heffess CS. Solid-pseudopapillary tumor of the pancreas: A typically cystic carcinoma of low malignant potential. Semin Diagn Pathol. 2000;17:66-80.
64. Klimstra DS, Longnecker D. Acinar cell carcinoma. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 241-243.
65. Stelow EB, Bardales RH, Shami VM, et al. Cytology of pancreatic acinar cell carcinoma. Diagn Cytopathol. 2006;34:367-372.
66. Klimstra DS, Longnecker D. Pancreatoblastoma. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 244-245.
67. Abraham SC, Wu TT, Klimstra DS, et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: Frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol. 2001;159:1619-1627.
68. Tanaka Y, Kato K, Notohara K, et al. Significance of aberrant (cytoplasmic/ nuclear) expression of beta-catenin in pancreatoblastoma. J Pathol. 2003;199:185-190.